May 26, 2022Alpha Tau Medical Announces First Quarter 2022 Financial Results and Provides Corporate Update-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $104 million in gross proceeds-...
May 24, 2022First Alpha DaRT Patients Treated in France as Part of Alpha DaRT™ Multicenter Skin Cancer TrialJERUSALEM, May 23, 2022 -- Alpha Tau Medical (Nasdaq: DRTS) (Nasdaq: DRTSW), the developer of the pioneering alpha-radiation cancer...